A Study to Identify and Characterise Patients with Chronic Kidney Disease and Proteinuria

Study identifier:D4325C00007

ClinicalTrials.gov identifier:NCT05967806

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

An international, non-randomised, non-interventional, multicentre study to identify and characterise patients with CKD and high proteinuria for possible participation in future renal clinical studies.

Medical condition

Renal disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

3000

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 31 Jul 2023
Estimated Primary Completion Date: 21 Aug 2024
Estimated Study Completion Date: 21 Aug 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria